(Total Views: 782)
Posted On: 03/05/2021 6:12:47 PM
Post# of 153963
Quote:
"The Company is very excited about these results and is concurrently working with regulators here and abroad to expedite leronlimab’s approval to treat COVID-19.”
I don't see how NP could legally state they're working to "expedite" approval unless approval was very much in the cards.
(9)
(0)
